Role of Tranexamic Acid in Reducing Blood Loss During Abdominal Myomectomy
DOI:
https://doi.org/10.61841/7e5mk429Keywords:
Myomectomy, Tranexamic Acid, ,Uterine LeiomyomasAbstract
Leiomyoma is benign, monoclonal tumor of the smooth muscle cells of the myometrium. This study aimed to reducing blood loss during myomectomy using either intravenousor topical method. Methods: This study was randomized controlled trials included 60 women undergoing abdominal myomectomy for symptomatic uterine leiomyomas in Department of Obstetrics and Gynecology, at Zagazig University Hospital during the period study year October 2019 to April 2020. Study inclusion criteria were women who attended the outpatient gynecology clinic, seeking treatment for symptomatic leiomyomas and scheduled to undergo abdominal myomectomy with myoma staging from (3 to 6) according to FIGO staging. The primary outcome was intra-operative, postoperative and all blood loss estimation. Results: There was statistically significant difference between the studied groups regarding blood loss with higher blood loss either intraoperative, postoperative and overall blood loss on control than topical than intra venous tranxamic acid group (p-value= 0.8, 0.9 and 0.9) respectively. Regarding need for blood transfusion where (50.0%) of the control group needed blood transfusion while only (10.0%) of intravenous and topicaltranexamic acid groups needed blood transfusion (pvalue= 0.003*). Conclusions: Intravenous and topical tranexamic acid safe and reliable method to help decrease blood loss during open myomectomy without serious side effects
Downloads
References
1. Lotfy M., Ibrahim Z., Abbas A., et al. Tranexamic Acid versus Carbetocin for Reduction of Blood Loss
during Abdominal Myomectomy: A Randomized Clinical Trial. W J Gynecol Women’s Health. 2020: 3(4).
2. Hamoodi, I. Investigating the effect of uterine artery embolisation on the uterus of women with fibroids and
heavy menstrual bleeding (Doctoral dissertation, University of Glasgow). (2017).
3. Sallam H, Shady N. Intravenous Carbetocin to decrease blood loss during open myomectomy: a randomized
placebo-controlled study. IJRCOG. 2018; 7(1): 27-32.
4. Donnez J, Dolmans MD. Uterine fibroid management: from the present to the future. Hum Reprod Update.
2016; 22(6): 665-86.
5. Shady NW, Sallam HF, Fahmy H.Reducing blood loss during open myomectomy with intravenous versus
topical tranexamic acid: A double-blinded randomized placebo-controlled trial. Middle East Fertility Society
Journal (MERS). 2018; 23: 225-31.
6. Shaaban MM, Ahmed MR, Farhan RE, Dardeer HH. Efficacy of tranexamic acid on myomectomy-associated
blood loss in patients with multiple myomas: a randomized controlled clinical trial. Reprod Sci. 2016; 23(7):
908-912.
7. Wang D, Wang L, Wang Y, Lin X.The efficiency and safety of tranexamic acid for reducing blood loss in
open myomectomy. A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2018; 97(4):
e9793.
8. Caglar GS, Tasci Y, Kayikcioglu F, Haberal A. Intravenous tranexamic acid use in myomectomy:
aprospective randomized double-blind placebo controlledstudy. Eur J Obstet Gynecol Reprod Biol. 2008;
137: 227.
9. Ngichabe S, Obura T, Stones W. Intravenous tranexamic acid as an adjunct haemostat to ornipressin during
open myomectomy. A randomized double-blind placebo controlled trial. Ann Surg Innov Res.2015; 9(1):10.
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
